Maximal inhibition of intestinal first-pass metabolism as a pragmatic indicator of intestinal contribution to the drug-drug interactions for CYP3A4 cleared drugs. - Galetin,A.; Hinton,L.K.; Burt,H.; Obach,R.S.; Houston,J.B. (Current Drug Metab, 2007)